What it's for (Indications)
- Clotrimazole + Gentamicin topical preparation is indicated for the treatment of various dermatological conditions characterized by mixed bacterial and fungal infections.
- This includes cases where susceptible dermatophytes, yeasts, and other fungi are present alongside susceptible gram-positive and gram-negative bacteria.
- Common indications encompass tinea infections (e.
- g.
- , tinea pedis, tinea cruris, tinea corporis) complicated by secondary bacterial infections, cutaneous candidiasis, and other superficial skin mycoses that are concurrently infected with bacteria sensitive to gentamicin.
- The combination is particularly useful when both fungal and bacterial pathogens contribute to the clinical presentation, necessitating a broad-spectrum therapeutic approach to effectively manage the infectious component and promote healing.
- Selection of this combination should be based on clinical presentation, or ideally, after confirmation of both bacterial and fungal etiologies through appropriate microbiological cultures and susceptibility testing, especially in persistent or recurrent cases.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For topical application, Clotrimazole + Gentamicin should be applied thinly to the affected skin area, typically once or twice daily, as directed by a healthcare professional. The precise duration of treatment is contingent upon the severity and nature of the infection, as well as the patient's clinical response to therapy. It is crucial to continue treatment for the full prescribed duration, even if symptoms improve, to ensure complete eradication of the infection and prevent recurrence. Patients should be instructed to wash their hands thoroughly before and after application. The treated area may be gently massaged until the cream or ointment disappears. Occlusive dressings are generally not recommended unless specifically advised by a physician, as they may enhance systemic absorption, particularly of gentamicin. Dosage adjustments or prolonged use beyond four weeks should be carefully re-evaluated by a clinician, considering potential risks of systemic absorption and the development of antimicrobial resistance. |
Safety & Warnings
Common Side Effects
- Commonly reported side effects associated with topical Clotrimazole + Gentamicin include localized reactions such as burning, stinging, erythema (redness), pruritus (itching), dryness, and irritation at the application site.
- These local reactions are generally mild and transient.
- Less frequently, patients may experience skin discoloration, follicular rash, or development of papules.
- Hypersensitivity reactions, including contact dermatitis, may occur in susceptible individuals to either clotrimazole or gentamicin, or other excipients present in the formulation.
- Prolonged or extensive use, particularly over large body surface areas, damaged skin, or under occlusive dressings, may rarely lead to systemic absorption of gentamicin, which carries risks of ototoxicity (hearing impairment) and nephrotoxicity (kidney damage), although this is extremely rare with proper topical use.
- The potential for superinfection with non-susceptible organisms, including fungi or bacteria, exists with prolonged antibiotic use.
Serious Warnings
- Black Box Warning: This topical formulation of Clotrimazole + Gentamicin does not carry a specific FDA Black Box Warning. However, it is imperative for healthcare providers and patients to be aware of the serious potential risks associated with its components, particularly gentamicin, if significant systemic absorption occurs. **Serious Warnings:** Gentamicin, an aminoglycoside antibiotic, is known to be associated with **ototoxicity (both auditory and vestibular)** and **nephrotoxicity (kidney damage)** when administered systemically. While systemic absorption from topical application on intact skin is minimal, the risk increases significantly with prolonged use, application to large body surface areas, damaged or broken skin, or under occlusive dressings. **Children, especially infants, and patients with pre-existing renal impairment are at an increased risk for these systemic toxicities due to potentially higher absorption rates or reduced clearance.** Close monitoring for signs of ototoxicity (e.g., hearing loss, tinnitus, dizziness, vertigo) or nephrotoxicity (e.g., elevated serum creatinine, decreased urine output) is crucial if conditions facilitating systemic absorption are present or suspected. Discontinue treatment immediately and seek medical attention if any signs of systemic adverse effects develop. The benefits of this combination product should be carefully weighed against these potential serious risks, particularly in vulnerable populations or when extensive application is required.
- Clotrimazole + Gentamicin is intended for external topical use only and should not be applied to the eyes, mouth, or other mucous membranes.
- Patients should be advised to avoid contact with these areas.
- Discontinue use if irritation, sensitization, or new signs of infection develop; a physician should be consulted promptly for re-evaluation.
- Prolonged use of topical antibiotics, including gentamicin, may lead to the overgrowth of non-susceptible bacteria or fungi, potentially resulting in superinfection.
- If this occurs, appropriate alternative therapy should be instituted.
- Caution is advised when applying to large surface areas, to broken or damaged skin, or in conjunction with occlusive dressings, as these conditions can increase the systemic absorption of gentamicin, thereby escalating the risk of systemic adverse effects, particularly in infants, children, and patients with pre-existing renal impairment.
- This product should be used with caution during pregnancy and lactation only if the potential benefit justifies the potential risk to the fetus or infant, and under strict medical supervision.
How it Works (Mechanism of Action)
The therapeutic efficacy of Clotrimazole + Gentamicin arises from the synergistic action of its two active components. **Clotrimazole**, an imidazole antifungal agent, exerts its fungicidal and fungistatic effects by inhibiting the biosynthesis of ergosterol, a crucial component of the fungal cell membrane. This inhibition leads to structural and functional impairment of the fungal cell membrane, resulting in altered permeability, leakage of essential intracellular components, and ultimately, fungal cell death. It is effective against a broad spectrum of pathogenic fungi, including dermatophytes, yeasts (e.g., Candida species), and Malassezia furfur. **Gentamicin**, an aminoglycoside antibiotic, acts by irreversibly binding to the 30S ribosomal subunit of susceptible bacteria. This binding interferes with bacterial protein synthesis, leading to the formation of abnormal, non-functional proteins, disruption of bacterial cell membrane integrity, and ultimately, bacterial cell death. Gentamicin exhibits broad-spectrum activity against many gram-negative bacteria (e.g., Pseudomonas aeruginosa, Escherichia coli, Klebsiella species, Enterobacter species) and some gram-positive bacteria (e.g., Staphylococcus aureus).
Commercial Brands (Alternatives)
No other brands found for this formula.